COMPOSITIONS COMPRISING HEMP EXTRACT AND RELATED TEATMENT METHODS
This disclosure relates to non-naturally occurring hemp extracts comprising cannabinoids and related treatment methods.
1 . A hemp extract comprising
20 mg/mL to 70 mg/mL of cannabidiol and
20 mg/mL to 70 mg/mL cannabidiolic acid;
wherein other cannabinoids are present at less than 5 mg/mL, individually.
2 - 7 . (canceled)
8 . A hemp extract comprising
20 mg/mL to 70 mg/mL of cannabigerol and
25 mg/mL to 70 mg/mL cannabigerolic acid;
wherein other cannabinoids are present at less than 5 mg/mL, individually.
9 - 14 . (canceled)
15 . A hemp extract comprising
20 mg/mL to 70 mg/mL of cannabidiolic acid;
20 mg/mL to 70 mg/mL cannabigerolic acid; and
1 mg/mL to 10 mg/mL of cannabigerol;
wherein any other cannabinoids are present at less than 5 mg/mL, individually.
16 - 21 . (canceled)
22 . A hemp extract comprising
10 mg/mL to 50 mg/mL of cannabidiol;
5 mg/mL to 35 mg/mL cannabidiolic acid;
5 mg/mL to 35 mg/mL of cannabidivarin;
3 mg/mL to 25 mg/mL cannabidivarinic acid; and
3 mg/mL to 20 mg/mL of cannabigerolic acid;
wherein other cannabinoids are present at less than 5 mg/mL, individually.
23 - 24 . (canceled)
25 . A hemp extract comprising
20 mg/mL to 40 mg/mL of cannabidiol;
10 mg/mL to 30 mg/mL cannabidiolic acid;
15 mg/mL to 30 mg/mL of cannabidivarin;
10 mg/mL to 20 mg/mL cannabidivarinic acid; and
8 mg/mL to 20 mg/mL of cannabigerolic acid;
wherein other cannabinoids are present at less than 5 mg/mL, individually.
26 . A hemp extract comprising
5 mg/mL to 30 mg/mL of cannabidiol;
5 mg/mL to 30 mg/mL cannabidiolic acid;
5 mg/mL to 30 mg/mL of cannabidivarin; and
5 mg/mL to 30 mg/mL cannabidivarinic acid.
27 - 29 . (canceled)
30 . A hemp extract comprising
20 mg/mL to 60 mg/mL of cannabidiol;
20 mg/mL to 60 mg/mL of cannabidiolic acid; and
5 mg/mL to 30 mg/mL of cannabinol;
wherein other cannabinoids are present at less than 5 mg/mL, individually.
31 - 35 . (canceled)
36 . A hemp extract comprising:
20 mg/mL to 50 mg/mL of cannabidiol;
5 mg/mL to 25 mg/mL of cannabigerol; and
5 mg/mL to 25 mg/mL of cannabigerolic acid;
wherein other cannabinoids are present at less than 5 mg/mL, individually.
37 - 38 . (canceled)
39 . A hemp extract comprising:
5 mg/mL to 70 mg/mL of cannabidiolic acid;
5 mg/mL to 70 mg/mL of cannabigerolic acid; and
5 mg/mL to 70 mg/mL of cannabidivarinic acid,
wherein other cannabinoids are present at less than 5 mg/mL, individually.
40 - 53 . (canceled)
54 . A dosage form comprising the hemp extract of claim 1 , wherein the dosage form comprises at least one of a pharmaceutically acceptable additive, a flavoring agent, a surfactant, and an adjuvant.
55 - 78 . (canceled)
79 . A method for treating chronic pain, anxiety, or inflammatory bowel disease in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 1 .
80 - 88 . (canceled)
89 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 8 .
90 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 15 .
91 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 22 .
92 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 25 .
93 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 26 .
94 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 30 .
95 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 36 .
96 . A method for treating chronic pain, anxiety, inflammatory bowel disease, or a sleep disorder in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the hemp extract of claim 39 .